Many of you joined us last spring for the inaugural AUA Innovation Nexus Conference. We were delighted to see the excitement around that event and have been working to channel that energy into our 2024 programming.

The 2024 Innovation Nexus Conference will be held ahead of our Annual Meeting on May 2 in San Antonio, Texas. It will feature discussion forums, reverse pitches, mentorship opportunities, and showcase presentations. New to the conference this year we’ll also have an Emerging Concepts session that will highlight a selection of compelling early-stage urology innovators and their ideas workshopped at the Nexus Boot Camp last fall.

Additionally, we’re excited to hear from Meghan Scanlon, senior vice president and president of urology at Boston Scientific, as our keynote speaker.

Showcase Presenters

The 2024 Showcase Presenters (Figure) will have the opportunity to pitch their ideas to a panel of individuals and the conference audience, including corporations, looking to invest in urology.

Figure. The 10 companies selected as Showcase Presenters for the 2024 Innovation Nexus Conference.

These 10 companies span the globe from Sweden to Japan to the United States and will present products—devices, artificial intelligence platforms, diagnostic tests, etc—covering a variety of urologic issues such as bladder cancer, urethral injuries, incontinence, fertility testing, bladder infections, and prostate cancer.

• CathBuddy has developed the Aurie System, a reusable no-touch catheter system which provides reduced UTI rates.
• Class Medical Ltd, formed by the University of Limerick, created a TransUrethral Catheter Safety Valve, a cost-effective catheterization safety device protecting patients by preventing trauma caused by balloon inflation in the urethra.
• Illumicell is leveraging patented artificial intelligence technology and proprietary hardware to empower doctors with advanced tools to make complex fertility assessments simple, accurate, and accessible.
• Juniper Biomedical is developing an implantable precision neuromodulation device to treat mixed urinary incontinence and other pelvic health conditions.
• NeoRene’s patented technology provides point-of-care diagnostics for real-time measurement and monitoring of urinary oxalates to aid patients in managing hyperoxaluria.
• Unicus Pharmaceutical LLC’s patented SENSEUO technology uses urine odor eliminating material to help people suffering from adult urinary incontinence or exposed to mammalian urine malodor.
• Vesica AI is developing an examination support system utilizing information technology and artificial intelligence for cystoscopy used in diagnosing and treating bladder cancer.
• Watershed Therapeutics has developed a long-lasting drug delivery therapy to reduce bladder infections in women.
• Xaga Surgical is a Swedish company working on the Forsvall biopsy instrument, which aims to increase patient safety and diagnostics in both transrectal and transperineal prostate cancer biopsies.
• Xeos Medical has developed a compact, mobile, high-resolution positron emission tomography—CT imager to enhance prostate-specific membrane antigen targeted therapy in treatment of prostate cancer.

As you know, Innovation Nexus serves as a powerful forum for advancing urologic discovery to improve patient care and save lives. We hope you’ll join us in May!

Visit auanexus.org to learn more and register.